2018 annual financial data
China SXT Pharmaceuticals 2018 Operating cash flow growth
Direct answer
Operating cash flow growth was 555.25%.
Operating income was 1,632,266 USD and net income was 1,187,581 USD.
Operating cash flow was 1,920,161 USD.
Get free China SXT Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 7,019,243 USD
- Operating income
- 1,632,266 USD
- Net income
- 1,187,581 USD
- Operating cash flow
- 1,920,161 USD